Dr. James Lett, MD

NPI: 1962507418
Total Payments
$32,769
2024 Payments
$5,598
Companies
7
Transactions
41

Payment Breakdown by Category

Consulting$28,487 (86.9%)
Travel$3,165 (9.7%)
Food & Beverage$1,117 (3.4%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $28,487 10 86.9%
Travel and Lodging $3,165 12 9.7%
Food and Beverage $1,117 19 3.4%

Top Paying Companies

Company Total Records Latest Year
Otsuka America Pharmaceutical, Inc. $15,715 15 $0 (2024)
Merck Sharp & Dohme LLC $7,552 10 $0 (2023)
ACADIA Pharmaceuticals Inc $7,211 11 $0 (2019)
Ferring Pharmaceuticals Inc. $2,160 1 $0 (2020)
Sumitomo Pharma America, Inc. $69.28 1 $0 (2023)
Pacira Pharmaceuticals Incorporated $39.22 2 $0 (2020)
Novartis Pharmaceuticals Corporation $22.78 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $5,598 5 Otsuka America Pharmaceutical, Inc. ($5,598)
2023 $2,859 3 Merck Sharp & Dohme LLC ($1,740)
2022 $9,162 9 Otsuka America Pharmaceutical, Inc. ($7,567)
2021 $1,500 1 Otsuka America Pharmaceutical, Inc. ($1,500)
2020 $2,199 3 Ferring Pharmaceuticals Inc. ($2,160)
2019 $11,428 19 ACADIA Pharmaceuticals Inc ($7,211)
2018 $22.78 1 Novartis Pharmaceuticals Corporation ($22.78)

All Payment Transactions

41 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
09/16/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Consulting Fee Cash or cash equivalent $5,177.50 General
Category: PSYCHIATRY
09/16/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Travel and Lodging Cash or cash equivalent $325.62 General
Category: PSYCHIATRY
09/16/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Travel and Lodging Cash or cash equivalent $58.30 General
Category: PSYCHIATRY
09/16/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Travel and Lodging Cash or cash equivalent $29.00 General
Category: PSYCHIATRY
09/16/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage Cash or cash equivalent $7.77 General
Category: PSYCHIATRY
12/13/2023 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $1,740.00 General
04/25/2023 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Consulting Fee Cash or cash equivalent $1,050.00 General
Category: PSYCHIATRY
03/13/2023 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $69.28 General
Category: Urology
12/12/2022 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Travel and Lodging Cash or cash equivalent $44.00 General
Category: PSYCHIATRY
12/06/2022 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Consulting Fee Cash or cash equivalent $5,544.00 General
Category: PSYCHIATRY
11/11/2022 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $49.99 General
Category: PSYCHIATRY
11/11/2022 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $49.97 General
Category: PSYCHIATRY
11/11/2022 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $36.33 General
Category: PSYCHIATRY
11/10/2022 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Travel and Lodging In-kind items and services $261.72 General
Category: PSYCHIATRY
11/10/2022 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $110.57 General
Category: PSYCHIATRY
08/11/2022 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Consulting Fee Cash or cash equivalent $1,470.00 General
Category: PSYCHIATRY
06/24/2022 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $1,595.00 General
05/19/2021 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Consulting Fee Cash or cash equivalent $1,500.00 General
Category: PSYCHIATRY
11/13/2020 Ferring Pharmaceuticals Inc. Consulting Fee Cash or cash equivalent $2,160.00 General
03/04/2020 Pacira Pharmaceuticals Incorporated EXPAREL (Drug) Food and Beverage In-kind items and services $22.17 General
Category: PAIN MANAGEMENT
03/03/2020 Pacira Pharmaceuticals Incorporated EXPAREL (Drug) Food and Beverage In-kind items and services $17.05 General
Category: PAIN MANAGEMENT
12/16/2019 Merck Sharp & Dohme Corporation Consulting Fee Cash or cash equivalent $3,250.00 General
12/16/2019 Merck Sharp & Dohme Corporation Travel and Lodging Cash or cash equivalent $150.00 General
12/12/2019 Merck Sharp & Dohme Corporation Food and Beverage In-kind items and services $64.99 General
12/12/2019 Merck Sharp & Dohme Corporation Food and Beverage In-kind items and services $59.99 General

About Dr. James Lett, MD

Dr. James Lett, MD is a Geriatric Medicine healthcare provider based in Rockville, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962507418.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Lett, MD has received a total of $32,769 in payments from pharmaceutical and medical device companies, with $5,598 received in 2024. These payments were reported across 41 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($28,487).

Practice Information

  • Specialty Geriatric Medicine
  • Location Rockville, MD
  • Active Since 09/13/2006
  • Last Updated 12/01/2011
  • Taxonomy Code 207RG0300X
  • Entity Type Individual
  • NPI Number 1962507418

Products in Payments

  • REXULTI (Drug) $15,715
  • NUPLAZID (Drug) $7,211
  • GEMTESA (Drug) $69.28
  • EXPAREL (Drug) $39.22

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Geriatric Medicine Doctors in Rockville